Trial Profile
A Phase 2 Study of E7070, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-risk Myelodysplastic Syndromes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Indisulam (Primary) ; Cytarabine; Dexamethasone; Idarubicin
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 16 Apr 2018 Final results published in the Cancer
- 12 Dec 2017 Final results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
- 13 Jun 2017 Status changed from active, no longer recruiting to completed.